Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma

BACKGROUND: DLC2, a unique RhoGAP, has been recently identified as a tumor suppressor gene in hepatocellular carcinoma (HCC). However, the expression of DLC2 protein, and its relationship with RhoA in clinical hepatocellular carcinoma have not been studied. The aim of this study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiaorong, Li, Wei, Wu, Liyuan, Qian, Kaiyan, Yang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496915/
https://www.ncbi.nlm.nih.gov/pubmed/18651974
http://dx.doi.org/10.1186/1471-2407-8-205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496915/
https://www.ncbi.nlm.nih.gov/pubmed/18651974
http://dx.doi.org/10.1186/1471-2407-8-205

Ejemplares similares